2/3-FEA 40 MG/120MG graanulid

2/3-FEA 40 MG / 120 MG Pellets – Scientific Product Description

General Information

2/3-FEA (2-Fluoroethamphetamine/3-Fluoroethamphetamine)  on  research compound from the fluoroamphetamine derivative family , with potential stimulant and empathogenic properties. These pellets contain a  precisely dosed combination of 40 mg 2-FEA and 120 mg 3-FEA , optimeeritud  preclinical studies  of pharmacodynamic interactions.

Applications & Research Areas

Due to its unique dual structure, 2/3-FEA is studied for:

1. Neurotransmitter research  – Effects on dopamine, norepinephrine, and serotonin release.

2. Käitumuslik farmakoloogia  – Influences on locomotor activity and reward systems in animal models.

3. Stimulant Effects  – Comparative Studies with Classical Amphetamines.

4. Receptor affinity studies  – Investigation of selectivity for monoamine transporters.

⚠ Not for human use – For in vitro and controlled animal testing only.

Dosage & Administration

Preclinical Guidelines:

• Low Active Range:  0.5-2 mg/kg (for subtle effects)

• Moderate Range:  2-5 mg/kg (clear behavioural effects)

• High Range:  5-10 mg/kg (for acute toxicity studies only)

Lahustuvus:

• Freely soluble in  füsioloogiline soolalahus  (for injection)

• Sparingly soluble in  DMSO  (for in vitro work)

Routes of administration:

• Oral (animal models)

• Intraperitoneal (for faster absorption)

• In vitro transporter assays

Safety Aspects & Risks

Acute Risks:

• Kardiovaskulaarne stress  (increased heart rate/blood pressure)

•  High-dose hyperthermia

• Serotonin syndrome  when combined with MAO inhibitors

Chronic Risks:

• Neurotoxicity  (at long-term high doses)

• Dopaminergic depletion

• Behavioral sensitization

Laboratory analysis & Quality control

Analytical Specifications:

• HPLC-MS confirmation  of composition

• Ratio 1:3 (2-FEA:3-FEA)  with <5% variance

• No detectable isomeric impurities

• Microbiological purity:  <100 CFU/g

Stabiilsusandmed:

• Säilivusaeg:  24 months at 4°C

• Photosensitivity:  Store in amber packaging

Recommended Research Protocols

1. Microdialysis Studies

   • Real-time monitoring of extracellular dopamine in nucleus accumbens

2. Tingimustega kohaeelistus

   • Reward potential evaluation

3. Thermoregulation Studies

   • Effects on body temperature

4. Elektrofüsioloogia

   • Firing pattern analysis of dopamine neurons

Korduma kippuvad küsimused

Q1: What is the main difference between 2-FEA and 3-FEA?
A: 2-FEA exhibits greater  dopaminergic selectivity , while 3-FEA has stronger  serotonergic effects  .

Q2: How does this combination compare to 3-FMA?
A: The 2/3-FEA combination has a  milder effect profile  with lower neurotoxicity potential.

Q3: Is there a risk of isomer formation?
A: Our analytical data shows that  no undesirable isomers  are formed when stored correctly.

Legal Note:
This product falls under the  Oopiumiseadus  in the Netherlands and is  intended solely for lawful scientific research  with the necessary permits.

Säilitamistingimused:

• Temperature: 2-8°C

• Protected from moisture and light

• Store away from food